News from the EU
- EU's Pharmacovigilance Risk Assessment Committee (PRAC) recommends strengthening the restrictions on the use of the epileptic medicine valproate (Deprakine etc.) in women and girls, page 2
- Monitoring of liver function during treatment with agomelatine (Valdoxan), page 3
- EU's list of recommendations on safety signals, page 4
News from the DHMA
- Ethambutol and effects on vision, page 5
- Safety of products containing botulinum toxin (Botox® etc.) and fillers for cosmetic treatment, page 6
News in brief
- Most recent Direct Healthcare Professional Communications (DHPCs), page 9
- Domperidone and new dosage recommendations – clarification of DHPC, page 9